MARKET

LFVN

LFVN

LifeVantage
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.71
+0.23
+2.19%
After Hours: 10.71 0 0.00% 16:00 04/03 EDT
OPEN
10.48
PREV CLOSE
10.48
HIGH
10.84
LOW
9.84
VOLUME
105.63K
TURNOVER
--
52 WEEK HIGH
17.25
52 WEEK LOW
7.75
MARKET CAP
153.79M
P/E (TTM)
13.51
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LFVN stock price target is 20.00 with a high estimate of 20.00 and a low estimate of 20.00.

EPS

LFVN News

More
  • What Is LifeVantage's (NASDAQ:LFVN) P/E Ratio After Its Share Price Tanked?
  • Simply Wall St. · 03/13 14:33
  • Are LifeVantage Corporations (NASDAQ:LFVN) High Returns Really That Great?
  • Simply Wall St. · 02/17 14:59
  • MMLP, I, NNVC and ARAY among midday movers
  • Seeking Alpha - Article · 01/29 17:40
  • LifeVantage Corp (LFVN) CEO Darren Jensen on Q2 2020 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 01/29 02:15

Industry

Pharmaceuticals
-0.14%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About LFVN

LifeVantage Corporation is focused on bio-hacking the aging code through nutrigenomics. The Company is helping people their health, wellness and financial independence goals. The Company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim Nrf2 synergizer, Protandim NRF1 synergizer, LifeVantage TrueScience, Petandim for dogs, and Axio. It sells products in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands and Germany.
More

Webull offers kinds of LifeVantage Corp stock information, including NASDAQ:LFVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFVN stock news, and many more online research tools to help you make informed decisions.